Palleon Pharmaceuticals Inc

Start Date End Date Funded Value Relevance

CSV

25 50 100

£531,067

Aug 12 - Aug 15

Development of a novel anti-inflammatory nanoparticle for the treatment of Acute Lung Injury

MRC award to Queen's University Belfast and Christopher Scott

£480,719

Nov 12 - Jan 16

Defining the role of aberrant O-linked glycosylation in breast cancer

MRC award to King's College London and Joy Burchell

£434,553

Aug 17 - Apr 21

The MUC1-ST/Siglec-9 innate check point axis in cancer: prevalence, prognostic significance and potential therapeutics.

MRC award to King's College London and Joy Burchell

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}